{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:57:10Z","timestamp":1789397830369,"version":"build-2803163510"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-23-0031"],"award-info":[{"award-number":["APVV-23-0031"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-23-0031"],"award-info":[{"award-number":["APVV-23-0031"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-23-0031"],"award-info":[{"award-number":["APVV-23-0031"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-23-0031"],"award-info":[{"award-number":["APVV-23-0031"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-23-0031"],"award-info":[{"award-number":["APVV-23-0031"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Operational Program Integrated Infrastructure (OPII) funded by the ERDF","award":["PROBIO-3 ITMS2014+: 313011T651"],"award-info":[{"award-number":["PROBIO-3 ITMS2014+: 313011T651"]}]},{"name":"Operational Program Integrated Infrastructure (OPII) funded by the ERDF","award":["PROBIO-3 ITMS2014+: 313011T651"],"award-info":[{"award-number":["PROBIO-3 ITMS2014+: 313011T651"]}]},{"name":"Operational Program Integrated Infrastructure (OPII) funded by the ERDF","award":["PROBIO-3 ITMS2014+: 313011T651"],"award-info":[{"award-number":["PROBIO-3 ITMS2014+: 313011T651"]}]},{"name":"Operational Program Integrated Infrastructure (OPII) funded by the ERDF","award":["PROBIO-3 ITMS2014+: 313011T651"],"award-info":[{"award-number":["PROBIO-3 ITMS2014+: 313011T651"]}]},{"name":"Operational Program Integrated Infrastructure (OPII) funded by the ERDF","award":["PROBIO-3 ITMS2014+: 313011T651"],"award-info":[{"award-number":["PROBIO-3 ITMS2014+: 313011T651"]}]},{"name":"Operational Program Integrated Infrastructure (OPII) funded by the ERDF","award":["PROBIO-3 ITMS2014+: 313011T651"],"award-info":[{"award-number":["PROBIO-3 ITMS2014+: 313011T651"]}]},{"name":"Operational Program Integrated Infrastructure (OPII) funded by the ERDF","award":["PROBIO-3 ITMS2014+: 313011T651"],"award-info":[{"award-number":["PROBIO-3 ITMS2014+: 313011T651"]}]},{"name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja,Slovakia","award":["APVV-16-0176"],"award-info":[{"award-number":["APVV-16-0176"]}]},{"name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja,Slovakia","award":["APVV-16-0176"],"award-info":[{"award-number":["APVV-16-0176"]}]},{"name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja,Slovakia","award":["APVV-16-0176"],"award-info":[{"award-number":["APVV-16-0176"]}]},{"name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja,Slovakia","award":["APVV-16-0176"],"award-info":[{"award-number":["APVV-16-0176"]}]},{"name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja,Slovakia","award":["APVV-16-0176"],"award-info":[{"award-number":["APVV-16-0176"]}]},{"name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja,Slovakia","award":["APVV-16-0176"],"award-info":[{"award-number":["APVV-16-0176"]}]},{"name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja,Slovakia","award":["APVV-16-0176"],"award-info":[{"award-number":["APVV-16-0176"]}]},{"name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja,Slovakia","award":["APVV-16-0176"],"award-info":[{"award-number":["APVV-16-0176"]}]},{"name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja,Slovakia","award":["APVV-16-0176"],"award-info":[{"award-number":["APVV-16-0176"]}]},{"name":"Operational Program Integrated Infrastructure","award":["Drive4SIFood 313011V336"],"award-info":[{"award-number":["Drive4SIFood 313011V336"]}]},{"name":"Operational Program Integrated Infrastructure","award":["Drive4SIFood 313011V336"],"award-info":[{"award-number":["Drive4SIFood 313011V336"]}]},{"name":"Operational Program Integrated Infrastructure","award":["Drive4SIFood 313011V336"],"award-info":[{"award-number":["Drive4SIFood 313011V336"]}]},{"name":"Operational Program Integrated Infrastructure","award":["Drive4SIFood 313011V336"],"award-info":[{"award-number":["Drive4SIFood 313011V336"]}]},{"name":"Operational Program Integrated Infrastructure","award":["Drive4SIFood 313011V336"],"award-info":[{"award-number":["Drive4SIFood 313011V336"]}]},{"name":"Operational Program Integrated Infrastructure","award":["Drive4SIFood 313011V336"],"award-info":[{"award-number":["Drive4SIFood 313011V336"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-025-04889-9","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T15:10:34Z","timestamp":1745248234000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Improvement of the inflammation-damaged intestinal barrier and modulation of the gut microbiota in ulcerative colitis after FMT in the SHIME\u00ae model"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7871-5338","authenticated-orcid":false,"given":"Anna","family":"Kaml\u00e1rov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9659-5584","authenticated-orcid":false,"given":"Monika","family":"Kvakov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4398-1665","authenticated-orcid":false,"given":"\u013dubo\u0161","family":"Ambro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3302-2244","authenticated-orcid":false,"given":"Ren\u00e9","family":"Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3076-2711","authenticated-orcid":false,"given":"Izabela","family":"Bertkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1552-7115","authenticated-orcid":false,"given":"Zdenka","family":"Hertelyov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3329-3968","authenticated-orcid":false,"given":"Martin","family":"Jan\u00ed\u010dko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8259-373X","authenticated-orcid":false,"given":"Em\u00edlia","family":"Hijov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9409-4153","authenticated-orcid":false,"given":"Jana","family":"\u0160tofilov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"issue":"12","key":"4889_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2019.02.004","volume":"65","author":"M Gajendran","year":"2019","unstructured":"Gajendran M, Loganathan P, Jimenez G, Catinella AP, Ng N, Umapathy C, Ziade N, Hashash JG. A comprehensive review and update on ulcerative colitis. Dis Mon. 2019;65(12): 100851. https:\/\/doi.org\/10.1016\/j.disamonth.2019.02.004.","journal-title":"Dis Mon"},{"issue":"1","key":"4889_CR2","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s12967-022-03569-3","volume":"20","author":"C Huang","year":"2022","unstructured":"Huang C, Huang Z, Ding L, Fu Y, Fan J, Mei Q, Lou L, Wang J, Yin N, Lu Y, Guo S, Zeng Y. Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis. J Transl Med. 2022;20(1):354. https:\/\/doi.org\/10.1186\/s12967-022-03569-3.","journal-title":"J Transl Med"},{"issue":"2","key":"4889_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.7861\/clinmed.2021-0080","volume":"21","author":"JP Segal","year":"2021","unstructured":"Segal JP, LeBlanc JF, Hart AL. Ulcerative colitis: an update. Clin Med (Lond). 2021;21(2):135\u20139. https:\/\/doi.org\/10.7861\/clinmed.2021-0080.","journal-title":"Clin Med (Lond)"},{"issue":"6","key":"4889_CR4","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s00281-019-00751-6","volume":"41","author":"MF Neurath","year":"2019","unstructured":"Neurath MF, Leppkes M. Resolution of ulcerative colitis. Semin Immunopathol. 2019;41(6):747\u201356. https:\/\/doi.org\/10.1007\/s00281-019-00751-6.","journal-title":"Semin Immunopathol"},{"issue":"10080","key":"4889_CR5","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","volume":"389","author":"R Ungaro","year":"2017","unstructured":"Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017;389(10080):1756\u201370. https:\/\/doi.org\/10.1016\/S0140-6736(16)32126-2.","journal-title":"Lancet"},{"issue":"4","key":"4889_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202103189","volume":"9","author":"NG Kotla","year":"2022","unstructured":"Kotla NG, Isa ILM, Rasala S, Demir S, Singh R, Baby BV, Swamy SK, Dockery P, Jala VR, Rochev Y, Pandit A. Modulation of Gut Barrier Functions in Ulcerative Colitis by Hyaluronic Acid System. Adv Sci (Weinh). 2022;9(4): e2103189. https:\/\/doi.org\/10.1002\/advs.202103189.","journal-title":"Adv Sci (Weinh)"},{"issue":"9","key":"4889_CR7","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.3390\/biomedicines10092236","volume":"10","author":"J \u0160tofilov\u00e1","year":"2022","unstructured":"\u0160tofilov\u00e1 J, Kvakov\u00e1 M, Kaml\u00e1rov\u00e1 A, Hijov\u00e1 E, Bertkov\u00e1 I, Gu\u013ea\u0161ov\u00e1 Z. Probiotic-Based Intervention in the Treatment of Ulcerative Colitis: Conventional and New Approaches. Biomedicines. 2022;10(9):2236. https:\/\/doi.org\/10.3390\/biomedicines10092236.","journal-title":"Biomedicines"},{"key":"4889_CR8","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3389\/fimmu.2019.00647","volume":"10","author":"R Curciarello","year":"2019","unstructured":"Curciarello R, Canziani KE, Docena GH, Muglia CI. Contribution of Non-immune Cells to Activation and Modulation of the Intestinal Inflammation. Front Immunol. 2019;10:647. https:\/\/doi.org\/10.3389\/fimmu.2019.00647.","journal-title":"Front Immunol"},{"key":"4889_CR9","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1146\/annurev-immunol-042718-041841","volume":"37","author":"EM Brown","year":"2019","unstructured":"Brown EM, Kenny DJ, Xavier RJ. Gut Microbiota Regulation of T Cells During Inflammation and Autoimmunity. Annu Rev Immunol. 2019;37:599\u2013624. https:\/\/doi.org\/10.1146\/annurev-immunol-042718-041841.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"4889_CR10","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a029314","volume":"10","author":"A Buckley","year":"2018","unstructured":"Buckley A, Turner JR. Cell Biology of Tight Junction Barrier Regulation and Mucosal Disease. Cold Spring Harb Perspect Biol. 2018;10(1): a029314. https:\/\/doi.org\/10.1101\/cshperspect.a029314.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"4889_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.519836","volume":"12","author":"HL Ser","year":"2021","unstructured":"Ser HL, Letchumanan V, Goh BH, Wong SH, Lee LH. The Use of Fecal Microbiome Transplant in Treating Human Diseases: Too Early for Poop? Front Microbiol. 2021;12: 519836. https:\/\/doi.org\/10.3389\/fmicb.2021.519836.","journal-title":"Front Microbiol"},{"issue":"2","key":"4889_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrgastro.2011.244","volume":"9","author":"TJ Borody","year":"2011","unstructured":"Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol. 2011;9(2):88\u201396. https:\/\/doi.org\/10.1038\/nrgastro.2011.244.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"4889_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5946\/ce.2019.009","volume":"52","author":"KO Kim","year":"2019","unstructured":"Kim KO, Gluck M. Fecal Microbiota Transplantation: An Update on Clinical Practice. Clin Endosc. 2019;52(2):137\u201343. https:\/\/doi.org\/10.5946\/ce.2019.009.","journal-title":"Clin Endosc"},{"issue":"4","key":"4889_CR14","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1136\/gutjnl-2017-313952","volume":"67","author":"T Zuo","year":"2018","unstructured":"Zuo T, Wong SH, Lam K, Lui R, Cheung K, Tang W, Ching JYL, Chan PKS, Chan MCW, Wu JCY, Chan FKL, Yu J, Sung JJY, Ng SC. Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome. Gut. 2018;67(4):634\u201343. https:\/\/doi.org\/10.1136\/gutjnl-2017-313952.","journal-title":"Gut"},{"key":"4889_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cofs.2018.02.011","volume":"20","author":"WW Thilakarathna","year":"2018","unstructured":"Thilakarathna WW, Langille MG, Rupasinghe HV. Polyphenol-based prebiotics and synbiotics: Potential for cancer chemoprevention. Curr Opin Food Sci. 2018;20:51\u20137. https:\/\/doi.org\/10.1016\/j.cofs.2018.02.011.","journal-title":"Curr Opin Food Sci"},{"issue":"104873","key":"4889_CR16","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/j.jff.2021.104873","volume":"88","author":"A Polo","year":"2022","unstructured":"Polo A, Cappello C, Carafa I, Da Ros A, Baccilieri F, Di Cagno R, Gobbetti M. A novel functional herbal tea containing probiotic Bacillus coagulans GanedenBC30: An in vitro study using the Simulator of the Human Intestinal Microbial Ecosystem (SHIME). J Funct Foods. 2022;88(104873):1756\u20134646. https:\/\/doi.org\/10.1016\/j.jff.2021.104873.","journal-title":"J Funct Foods"},{"key":"4889_CR17","doi-asserted-by":"publisher","unstructured":"Van de Wiele T, Van den Abbeele P, Ossieur W, Possemiers S, Marzorati M. The Simulator of the Human Intestinal Microbial Ecosystem (SHIME\u00ae). In: Verhoeckx K, Cotter P, L\u00f3pez-Exp\u00f3sito I, Kleiveland C, Lea T, Mackie A, Requena T, Swiatecka D, Wichers H, editors. The Impact of Food Bioactives on Health: in vitro and ex vivo models. Cham (CH): Springer. 2015;305\u2013317. https:\/\/doi.org\/10.1007\/978-3-319-16104-4_27.","DOI":"10.1007\/978-3-319-16104-4_27"},{"issue":"1","key":"4889_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bpg.2013.03.002","volume":"27","author":"K Venema","year":"2013","unstructured":"Venema K, Van den Abbeele P. Experimental models of the gut microbiome. Best Pract Res Clin Gastroenterol. 2013;27(1):115\u201326. https:\/\/doi.org\/10.1016\/j.bpg.2013.03.002.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"5","key":"4889_CR19","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/ismej.2012.158","volume":"7","author":"P Van den Abbeele","year":"2013","unstructured":"Van den Abbeele P, Belzer C, Goossens M, Kleerebezem M, De Vos WM, Thas O, De Weirdt R, Kerckhof FM, Van de Wiele T. Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model. ISME J. 2013;7(5):949\u201361. https:\/\/doi.org\/10.1038\/ismej.2012.158.","journal-title":"ISME J"},{"issue":"5","key":"4889_CR20","doi-asserted-by":"publisher","first-page":"959","DOI":"10.3390\/jcm10050959","volume":"10","author":"V Mocanu","year":"2021","unstructured":"Mocanu V, Rajaruban S, Dang J, Kung JY, Deehan EC, Madsen KL. Repeated Fecal Microbial Transplantations and Antibiotic Pre-Treatment Are Linked to Improved Clinical Response and Remission in Inflammatory Bowel Disease: A Systematic Review and Pooled Proportion Meta-Analysis. J Clin Med. 2021;10(5):959. https:\/\/doi.org\/10.3390\/jcm10050959.","journal-title":"J Clin Med"},{"issue":"1","key":"4889_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/MIB.0000000000000975","volume":"23","author":"D Ishikawa","year":"2017","unstructured":"Ishikawa D, Sasaki T, Osada T, Kuwahara-Arai K, Haga K, Shibuya T, Hiramatsu K, Watanabe S. Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis. Inflamm Bowel Dis. 2017;23(1):116\u201325. https:\/\/doi.org\/10.1097\/MIB.0000000000000975.","journal-title":"Inflamm Bowel Dis"},{"issue":"20","key":"4889_CR22","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.3390\/molecules24203791","volume":"24","author":"C Giuliani","year":"2019","unstructured":"Giuliani C, Marzorati M, Daghio M, Franzetti A, Innocenti M, Van de Wiele T, Mulinacci N. Effects of Olive and Pomegranate By-Products on Human Microbiota: A Study Using the SHIME\u00ae in Vitro Simulator. Molecules. 2019;24(20):3791. https:\/\/doi.org\/10.3390\/molecules24203791.","journal-title":"Molecules"},{"issue":"3","key":"4889_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s44164-022-00017-w","volume":"1","author":"A Joshi","year":"2022","unstructured":"Joshi A, Soni A, Acharya S. In vitro models and ex vivo systems used in inflammatory bowel disease. In Vitro Model. 2022;1(3):213\u201327. https:\/\/doi.org\/10.1007\/s44164-022-00017-w.","journal-title":"In Vitro Model"},{"key":"4889_CR24","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.tifs.2020.11.015","volume":"107","author":"X Ding","year":"2021","unstructured":"Ding X, Hu X, Chen Y, Xie J, Ying M, Wang Y, Qiang Y. Differentiated Caco-2 cell models in food-intestine interaction study: current applications and future trends. Trends Food Sci Technol. 2021;107:455\u201365. https:\/\/doi.org\/10.1016\/j.tifs.2020.11.015.","journal-title":"Trends Food Sci Technol"},{"issue":"4","key":"4889_CR25","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1021\/acs.molpharmaceut.6b01165","volume":"14","author":"I Lozoya-Agullo","year":"2017","unstructured":"Lozoya-Agullo I, Ara\u00fajo F, Gonz\u00e1lez-\u00c1lvarez I, Merino-Sanju\u00e1n M, Gonz\u00e1lez-\u00c1lvarez M, Bermejo M, Sarmento B. Usefulness of Caco-2\/HT29-MTX and Caco-2\/HT29-MTX\/Raji B Coculture Models To Predict Intestinal and Colonic Permeability Compared to Caco-2 Monoculture. Mol Pharm. 2017;14(4):1264\u201370. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b01165.","journal-title":"Mol Pharm"},{"key":"4889_CR26","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jnutbio.2008.05.006","volume":"20","author":"GJ Mahler","year":"2009","unstructured":"Mahler GJ, Shuler ML, Glahn RP. Characterization of Caco-2 and HT29-MTX co-cultures in an in vitro digestion\/cell culture model used to predict iron bioavailability. J Nutr Biochem United States. 2009;20:494\u2013502. https:\/\/doi.org\/10.1016\/j.jnutbio.2008.05.006.","journal-title":"J Nutr Biochem United States"},{"issue":"Pt B","key":"4889_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2020.114399","volume":"265","author":"L Liu","year":"2020","unstructured":"Liu L, Wang Q, Wu X, Qi H, Das R, Lin H, Shi J, Wang S, Yang J, Xue Y, Mao D, Luo Y. Vancomycin exposure caused opportunistic pathogens bloom in intestinal microbiome by simulator of the human intestinal microbial ecosystem (SHIME). Environ Pollut. 2020;265(Pt B): 114399. https:\/\/doi.org\/10.1016\/j.envpol.2020.114399.","journal-title":"Environ Pollut"},{"key":"4889_CR28","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jff.2015.11.005","volume":"20","author":"D Daguet","year":"2016","unstructured":"Daguet D, Pinheiro I, Verhelst A, Possemiers S, Marzorati M. Arabinogalactan and fructooligosaccharides improve the gut barrier function in distinct areas of the colon in the Simulator of the Human Intestinal Microbial Ecosystem. J Funct Food. 2016;20:369\u201379. https:\/\/doi.org\/10.1016\/j.jff.2015.11.005.","journal-title":"J Funct Food"},{"issue":"3","key":"4889_CR29","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1128\/aem.59.3.695-700.1993","volume":"59","author":"G Muyzer","year":"1993","unstructured":"Muyzer G, de Waal EC, Uitterlinden AG. Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl Environ Microbiol. 1993Mar;59(3):695\u2013700. https:\/\/doi.org\/10.1128\/aem.59.3.695-700.1993.","journal-title":"Appl Environ Microbiol"},{"issue":"6","key":"4889_CR30","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1128\/AEM.01036-05","volume":"72","author":"A Layton","year":"2006","unstructured":"Layton A, McKay L, Williams D, Garrett V, Gentry R, Sayler G. Development of Bacteroides 16S rRNA gene TaqMan-based real-time PCR assays for estimation of total, human, and bovine fecal pollution in water. Appl Environ Microbiol. 2006;72(6):4214\u201324. https:\/\/doi.org\/10.1128\/AEM.01036-05.","journal-title":"Appl Environ Microbiol"},{"issue":"9","key":"4889_CR31","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1128\/AEM.02195-07","volume":"74","author":"JK Brons","year":"2008","unstructured":"Brons JK, van Elsas JD. Analysis of bacterial communities in soil by use of denaturing gradient gel electrophoresis and clone libraries, as influenced by different reverse primers. Appl Environ Microbiol. 2008;74(9):2717\u201327. https:\/\/doi.org\/10.1128\/AEM.02195-07.","journal-title":"Appl Environ Microbiol"},{"issue":"6","key":"4889_CR32","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1111\/j.1365-2672.2004.02409.x","volume":"97","author":"T Rinttil\u00e4","year":"2004","unstructured":"Rinttil\u00e4 T, Kassinen A, Malinen E, Krogius L, Palva A. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol. 2004;97(6):1166\u201377. https:\/\/doi.org\/10.1111\/j.1365-2672.2004.02409.x.","journal-title":"J Appl Microbiol"},{"issue":"7","key":"4889_CR33","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1128\/JCM.42.7.3128-3136.2004","volume":"42","author":"R Byun","year":"2004","unstructured":"Byun R, Nadkarni MA, Chhour KL, Martin FE, Jacques NA, Hunter N. Quantitative analysis of diverse Lactobacillus species present in advanced dental caries. J Clin Microbiol. 2004;42(7):3128\u201336. https:\/\/doi.org\/10.1128\/JCM.42.7.3128-3136.2004.","journal-title":"J Clin Microbiol"},{"key":"4889_CR34","doi-asserted-by":"publisher","unstructured":"Heilig HG, Zoetendal EG, Vaughan EE, Marteau P, Akkermans AD, de Vos WM. Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA. Appl Environ Microbiol. 2002;68(1):114\u2013123.https:\/\/doi.org\/10.1128\/AEM.68.1.114-123.2002.","DOI":"10.1128\/AEM.68.1.114-123.2002"},{"issue":"2","key":"4889_CR35","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1128\/AEM.67.2.504-513.2001","volume":"67","author":"RM Satokari","year":"2001","unstructured":"Satokari RM, Vaughan EE, Akkermans AD, Saarela M, de Vos WM. Bifidobacterial diversity in human feces detected by genus-specific PCR and denaturing gradient gel electrophoresis. Appl Environ Microbiol. 2001;67(2):504\u201313. https:\/\/doi.org\/10.1128\/AEM.67.2.504-513.2001.","journal-title":"Appl Environ Microbiol"},{"key":"4889_CR36","unstructured":"https:\/\/support.illumina.com\/documents\/documentation\/chemistry_documentation\/16s\/16s-metagenomic-library-prep-guide-15044223-b.pdf.Cited 5.2.2025."},{"issue":"2","key":"4889_CR37","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/ismej.2016.117","volume":"11","author":"R Props","year":"2017","unstructured":"Props R, Kerckhof FM, Rubbens P, De Vrieze J, Hernandez Sanabria E, Waegeman W, Monsieurs P, Hammes F, Boon N. Absolute quantification of microbial taxon abundances. ISME J. 2017;11(2):584\u20137. https:\/\/doi.org\/10.1038\/ismej.2016.117.","journal-title":"ISME J"},{"issue":"46","key":"4889_CR38","doi-asserted-by":"publisher","first-page":"13102","DOI":"10.1021\/acs.jafc.9b05085","volume":"68","author":"P Van den Abbeele","year":"2020","unstructured":"Van den Abbeele P, Moens F, Pignataro G, Schnurr J, Ribecco C, Gramenzi A, Marzorati M. Yeast-Derived Formulations Are Differentially Fermented by the Canine and Feline Microbiome As Assessed in a Novel In Vitro Colonic Fermentation Model. J Agric Food Chem. 2020;68(46):13102\u201310. https:\/\/doi.org\/10.1021\/acs.jafc.9b05085.","journal-title":"J Agric Food Chem"},{"key":"4889_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119648","volume":"587","author":"J Ghyselinck","year":"2020","unstructured":"Ghyselinck J, Verstrepen L, Moens F, Van den Abbeele P, Said J, Smith B, Bjarnason I, Basit AW, Gaisford S. A 4-strain probiotic supplement influences gut microbiota composition and gut wall function in patients with ulcerative colitis. Int J Pharm. 2020;587: 119648. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119648.","journal-title":"Int J Pharm"},{"issue":"1","key":"4889_CR40","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1039\/c6fo01592a","volume":"8","author":"KK Putt","year":"2017","unstructured":"Putt KK, Pei R, White HM, Bolling BW. Yogurt inhibits intestinal barrier dysfunction in Caco-2 cells by increasing tight junctions. Food Funct. 2017;8(1):406\u201314. https:\/\/doi.org\/10.1039\/c6fo01592a.","journal-title":"Food Funct"},{"key":"4889_CR41","doi-asserted-by":"publisher","unstructured":"Steube A, Stallhofer J, Stallmach A. Fecal microbiota transfer to treat ulcerative colitis: Medical and legal challenges. Front Gastroenterol. 2023;2\u20132023. https:\/\/doi.org\/10.3389\/fgstr.2023.1161610.","DOI":"10.3389\/fgstr.2023.1161610"},{"key":"4889_CR42","doi-asserted-by":"publisher","first-page":"1049849","DOI":"10.3389\/fmed.2022.1049849","volume":"9","author":"S Tkach","year":"2023","unstructured":"Tkach S, Dorofeyev A, Kuzenko I, Falalyeyeva T, Tsyryuk O, Kovalchuk O, Kobyliak N, Abenavoli L, Boccuto L. Efficacy and safety of fecal microbiota transplantation via colonoscopy as add-on therapy in patients with mild-to-moderate ulcerative colitis: A randomized clinical trial. Front Med (Lausanne). 2023;9:1049849. https:\/\/doi.org\/10.3389\/fmed.2022.1049849.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"4889_CR43","doi-asserted-by":"publisher","first-page":"251","DOI":"10.5217\/ir.2021.00069","volume":"20","author":"AK Seth","year":"2022","unstructured":"Seth AK, Jain P. Fecal microbiota transplantation for induction of remission, maintenance and rescue in patients with corticosteroid-dependent ulcerative colitis: a long-term follow-up real-world cohort study. Intest Res. 2022;20(2):251\u20139. https:\/\/doi.org\/10.5217\/ir.2021.00069.","journal-title":"Intest Res"},{"issue":"2","key":"4889_CR44","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S2468-1253(21)00400-3","volume":"7","author":"C Haifer","year":"2022","unstructured":"Haifer C, Paramsothy S, Kaakoush NO, Saikal A, Ghaly S, Yang T, Luu LDW, Borody TJ, Leong RW. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial. Lancet Gastroenterol Hepatol. 2022;7(2):141\u201351. https:\/\/doi.org\/10.1016\/S2468-1253(21)00400-3.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"8","key":"4889_CR45","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1089\/jmf.2013.0092","volume":"17","author":"K Sivieri","year":"2014","unstructured":"Sivieri K, Morales ML, Saad SM, Adorno MA, Sakamoto IK, Rossi EA. Prebiotic effect of fructooligosaccharide in the simulator of the human intestinal microbial ecosystem (SHIME\u00ae model). J Med Food. 2014;17(8):894\u2013901. https:\/\/doi.org\/10.1089\/jmf.2013.0092.","journal-title":"J Med Food"},{"issue":"13","key":"4889_CR46","doi-asserted-by":"publisher","first-page":"6083896","DOI":"10.1155\/2022\/6083896","volume":"2022","author":"H Hamblin","year":"2022","unstructured":"Hamblin H, Gunaratne AW, Clancy A, Pilarinos D, LeBusque A, Dawson MVM, Borody TJ. Pre-Antibiotic Treatment Followed by Prolonged Repeated Faecal Microbiota Transplantation Improves Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome: An Observational Australian Clinical Experience. Gastroenterol Res Pract. 2022;2022(13):6083896. https:\/\/doi.org\/10.1155\/2022\/6083896.","journal-title":"Gastroenterol Res Pract"},{"issue":"1","key":"4889_CR47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bj.2021.11.004","volume":"45","author":"CC Chen","year":"2022","unstructured":"Chen CC, Chiu CH. Current and future applications of fecal microbiota transplantation for children. Biomed J. 2022;45(1):11\u20138. https:\/\/doi.org\/10.1016\/j.bj.2021.11.004.","journal-title":"Biomed J"},{"issue":"10075","key":"4889_CR48","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","volume":"389","author":"S Paramsothy","year":"2017","unstructured":"Paramsothy S, Kamm MA, Kaakoush NO, Walsh AJ, van den Bogaerde J, Samuel D, Leong RWL, Connor S, Ng W, Paramsothy R, Xuan W, Lin E, Mitchell HM, Borody TJ. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet. 2017;389(10075):1218\u201328. https:\/\/doi.org\/10.1016\/S0140-6736(17)30182-4.","journal-title":"Lancet"},{"issue":"1","key":"4889_CR49","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1080\/25785826.2020.1792040","volume":"44","author":"K Matsuoka","year":"2021","unstructured":"Matsuoka K. Fecal microbiota transplantation for ulcerative colitis. Immunol Med. 2021;44(1):30\u20134. https:\/\/doi.org\/10.1080\/25785826.2020.1792040.","journal-title":"Immunol Med"},{"issue":"3","key":"4889_CR50","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1080\/19490976.2017.1290757","volume":"8","author":"AR Weingarden","year":"2017","unstructured":"Weingarden AR, Vaughn BP. Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease. Gut Microbes. 2017;8(3):238\u201352. https:\/\/doi.org\/10.1080\/19490976.2017.1290757.","journal-title":"Gut Microbes"},{"issue":"4","key":"4889_CR51","first-page":"519","volume":"82","author":"C Blanchaert","year":"2019","unstructured":"Blanchaert C, Strubbe B, Peeters H. Fecal microbiota transplantation in ulcerative colitis. Acta Gastroenterol Belg. 2019;82(4):519\u201328.","journal-title":"Acta Gastroenterol Belg"},{"issue":"1","key":"4889_CR52","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12964-022-00869-5","volume":"20","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Zhang H, Chen T, Shi L, Wang D, Tang D. Regulatory role of short-chain fatty acids in inflammatory bowel disease. Cell Commun Signal. 2022;20(1):64. https:\/\/doi.org\/10.1186\/s12964-022-00869-5.","journal-title":"Cell Commun Signal"},{"key":"4889_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2021.108926","volume":"101","author":"JG Lee","year":"2022","unstructured":"Lee JG, Lee J, Lee AR, Jo SV, Park CH, Han DS, Eun CS. Impact of short-chain fatty acid supplementation on gut inflammation and microbiota composition in a murine colitis model. J Nutr Biochem. 2022;101: 108926. https:\/\/doi.org\/10.1016\/j.jnutbio.2021.108926.","journal-title":"J Nutr Biochem"},{"issue":"6","key":"4889_CR54","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/mds.28016","volume":"35","author":"C Shin","year":"2020","unstructured":"Shin C, Lim Y, Lim H, Ahn TB. Plasma Short-Chain Fatty Acids in Patients with Parkinson\u2019s Disease. Mov Disord. 2020;35(6):1021\u20137. https:\/\/doi.org\/10.1002\/mds.28016.","journal-title":"Mov Disord"},{"issue":"12","key":"4889_CR55","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1097\/MIB.0000000000000972","volume":"22","author":"K Takeshita","year":"2016","unstructured":"Takeshita K, Mizuno S, Mikami Y, Sujino T, Saigusa K, Matsuoka K, Naganuma M, Sato T, Takada T, Tsuji H, Kushiro A, Nomoto K, Kanai T. A Single Species of Clostridium Subcluster XIVa Decreased in Ulcerative Colitis Patients. Inflamm Bowel Dis. 2016;22(12):2802\u201310. https:\/\/doi.org\/10.1097\/MIB.0000000000000972.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"4889_CR56","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/j.1574-6941.2011.01252.x","volume":"79","author":"J Vermeiren","year":"2012","unstructured":"Vermeiren J, Van den Abbeele P, Laukens D, Vigsnaes LK, De Vos M, Boon N, Van de Wiele T. Decreased colonization of fecal Clostridium coccoides\/Eubacterium rectale species from ulcerative colitis patients in an in vitro dynamic gut model with mucin environment. FEMS Microbiol Ecol. 2012;79(3):685\u201396. https:\/\/doi.org\/10.1111\/j.1574-6941.2011.01252.x.","journal-title":"FEMS Microbiol Ecol"},{"issue":"1","key":"4889_CR57","first-page":"60","volume":"1","author":"B Gibbs","year":"2022","unstructured":"Gibbs B, Brown B. Butyrate therapy for treatment resistant ulcerative colitis: a case study. Nutr Med J. 2022;1(1):60\u20137.","journal-title":"Nutr Med J"},{"issue":"4","key":"4889_CR58","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3390\/immuno2040042","volume":"2","author":"S Ota","year":"2022","unstructured":"Ota S, Sakuraba H. Uptake and Advanced Therapy of Butyrate in Inflammatory Bowel Disease. Immuno. 2022;2(4):692\u2013702. https:\/\/doi.org\/10.3390\/immuno2040042.","journal-title":"Immuno"},{"key":"4889_CR59","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.3389\/fphar.2019.01553","volume":"10","author":"X Tang","year":"2020","unstructured":"Tang X, Li X, Wang Y, Zhang Z, Deng A, Wang W, Zhang H, Qin H, Wu L. Butyric Acid Increases the Therapeutic Effect of EHLJ7 on Ulcerative Colitis by Inhibiting JAK2\/STAT3\/SOCS1 Signaling Pathway. Front Pharmacol. 2020;10:1553. https:\/\/doi.org\/10.3389\/fphar.2019.01553.","journal-title":"Front Pharmacol"},{"issue":"10","key":"4889_CR60","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/ecco-jcc\/jjaa065","volume":"14","author":"D Bajic","year":"2020","unstructured":"Bajic D, Niemann A, Hillmer AK, Mejias-Luque R, Bluemel S, Docampo M, Funk MC, Tonin E, Boutros M, Schnabl B, Busch DH, Miki T, Schmid RM, van den Brink MRM, Gerhard M, Stein-Thoeringer CK. Gut Microbiota-Derived Propionate Regulates the Expression of Reg3 Mucosal Lectins and Ameliorates Experimental Colitis in Mice. J Crohns Colitis. 2020;14(10):1462\u201372. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa065.","journal-title":"J Crohns Colitis"},{"issue":"1","key":"4889_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1897212","volume":"13","author":"A Nogal","year":"2021","unstructured":"Nogal A, Valdes AM, Menni C. The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health. Gut Microbes. 2021;13(1):1\u201324. https:\/\/doi.org\/10.1080\/19490976.2021.1897212.","journal-title":"Gut Microbes"},{"key":"4889_CR62","doi-asserted-by":"publisher","first-page":"1174832","DOI":"10.3389\/fmicb.2023.1174832","volume":"14","author":"RH Dahal","year":"2023","unstructured":"Dahal RH, Kim S, Kim YK, Kim ES, Kim J. Insight into gut dysbiosis of patients with inflammatory bowel disease and ischemic colitis. Front Microbiol. 2023;14:1174832. https:\/\/doi.org\/10.3389\/fmicb.2023.1174832.","journal-title":"Front Microbiol"},{"issue":"1","key":"4889_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1875796","volume":"13","author":"X Liu","year":"2021","unstructured":"Liu X, Mao B, Gu J, Wu J, Cui S, Wang G, Zhao J, Zhang H, Chen W. Blautia-a new functional genus with potential probiotic properties? Gut Microbes. 2021;13(1):1\u201321. https:\/\/doi.org\/10.1080\/19490976.2021.1875796.","journal-title":"Gut Microbes"},{"key":"4889_CR64","doi-asserted-by":"publisher","first-page":"6481","DOI":"10.1016\/j.csbj.2021.11.037","volume":"19","author":"G Serrano-G\u00f3mez","year":"2021","unstructured":"Serrano-G\u00f3mez G, Mayorga L, Oyarzun I, Roca J, Borruel N, Casellas F, Varela E, Pozuelo M, Machiels K, Guarner F, Vermeire S, Manichanh C. Dysbiosis and relapse-related microbiome in inflammatory bowel disease: A shotgun metagenomic approach. Comput Struct Biotechnol J. 2021;19:6481\u20139. https:\/\/doi.org\/10.1016\/j.csbj.2021.11.037.","journal-title":"Comput Struct Biotechnol J"},{"issue":"4","key":"4889_CR65","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3390\/microorganisms8040573","volume":"8","author":"M Vacca","year":"2020","unstructured":"Vacca M, Celano G, Calabrese FM, Portincasa P, Gobbetti M, De Angelis M. The Controversial Role of Human Gut Lachnospiraceae. Microorganisms. 2020;8(4):573. https:\/\/doi.org\/10.3390\/microorganisms8040573.","journal-title":"Microorganisms"},{"issue":"5","key":"4889_CR66","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1053\/j.gastro.2018.12.001","volume":"156","author":"S Paramsothy","year":"2019","unstructured":"Paramsothy S, Nielsen S, Kamm MA, Deshpande NP, Faith JJ, Clemente JC, Paramsothy R, Walsh AJ, van den Bogaerde J, Samuel D, Leong RWL, Connor S, Ng W, Lin E, Borody TJ, Wilkins MR, Colombel JF, Mitchell HM, Kaakoush NO. Specific Bacteria and Metabolites Associated with Response to Fecal Microbiota Transplantation in Patients with Ulcerative Colitis. Gastroenterology. 2019;156(5):1440-1454.e2. https:\/\/doi.org\/10.1053\/j.gastro.2018.12.001.","journal-title":"Gastroenterology"},{"issue":"1","key":"4889_CR67","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1039\/d2fo02659g","volume":"14","author":"D Qu","year":"2023","unstructured":"Qu D, Yu L, Tian F, Zhang H, Chen W, Gu Z, Zhai Q. Bifidobacterium bifidum FJSWX19M5 alleviated 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced chronic colitis by mitigating gut barrier injury and increasing regulatory T cells. Food Funct. 2023;14(1):181\u201394. https:\/\/doi.org\/10.1039\/d2fo02659g.","journal-title":"Food Funct"},{"issue":"1","key":"4889_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1826746","volume":"13","author":"L Fan","year":"2021","unstructured":"Fan L, Qi Y, Qu S, Chen X, Li A, Hendi M, Xu C, Wang L, Hou T, Si J, Chen SB. adolescentis ameliorates chronic colitis by regulating Treg\/Th2 response and gut microbiota remodeling. Gut Microbes. 2021;13(1):1\u201317. https:\/\/doi.org\/10.1080\/19490976.2020.1826746.","journal-title":"Gut Microbes"},{"issue":"1","key":"4889_CR69","doi-asserted-by":"publisher","first-page":"18597","DOI":"10.1038\/s41598-020-75702-5","volume":"10","author":"S Singh","year":"2020","unstructured":"Singh S, Bhatia R, Khare P, Sharma S, Rajarammohan S, Bishnoi M, Bhadada SK, Sharma SS, Kaur J, Kiran KK. Anti-inflammatory Bifidobacterium strains prevent dextran sodium sulfate induced colitis and associated gut microbial dysbiosis in mice. Sci Rep. 2020;10(1):18597. https:\/\/doi.org\/10.1038\/s41598-020-75702-5.","journal-title":"Sci Rep"},{"issue":"8","key":"4889_CR70","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.4014\/jmb.2002.02058","volume":"30","author":"SK Han","year":"2020","unstructured":"Han SK, Kim JK, Joo MK, Lee KE, Han SW, Kim DH. Lactobacillus reuteri NK33 and Bifidobacterium adolescentis NK98 Alleviate Escherichia coli-Induced depression and Gut Dysbiosis in Mice. J Microbiol Biotechnol. 2020;30(8):1222\u20136. https:\/\/doi.org\/10.4014\/jmb.2002.02058.","journal-title":"J Microbiol Biotechnol"},{"issue":"4","key":"4889_CR71","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3390\/nu11040782","volume":"11","author":"R Yu","year":"2019","unstructured":"Yu R, Zuo F, Ma H, Chen S. Exopolysaccharide-Producing Bifidobacterium adolescentis Strains with Similar Adhesion Property Induce Differential Regulation of Inflammatory Immune Response in Treg\/Th17 Axis of DSS-Colitis Mice. Nutrients. 2019;11(4):782. https:\/\/doi.org\/10.3390\/nu11040782.","journal-title":"Nutrients"},{"issue":"12","key":"4889_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.cdnut.2023.102026","volume":"7","author":"R Abdulqadir","year":"2023","unstructured":"Abdulqadir R, Engers J, Al-Sadi R. Role of Bifidobacterium in Modulating the Intestinal Epithelial Tight Junction Barrier: Current Knowledge and Perspectives. Curr Dev Nutr. 2023;7(12): 102026. https:\/\/doi.org\/10.1016\/j.cdnut.2023.102026.","journal-title":"Curr Dev Nutr"},{"issue":"3","key":"4889_CR73","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3390\/microorganisms9030565","volume":"9","author":"B Cuffaro","year":"2021","unstructured":"Cuffaro B, Assohoun ALW, Boutillier D, Peucelle V, Desramaut J, Boudebbouze S, Croyal M, Waligora-Dupriet AJ, Rhimi M, Grangette C, Maguin E. Identification of New Potential Biotherapeutics from Human Gut Microbiota-Derived Bacteria. Microorganisms. 2021;9(3):565. https:\/\/doi.org\/10.3390\/microorganisms9030565.","journal-title":"Microorganisms"},{"key":"4889_CR74","doi-asserted-by":"publisher","first-page":"6025","DOI":"10.2147\/JIR.S300989","volume":"14","author":"MT Siddiqui","year":"2021","unstructured":"Siddiqui MT, Cresci GAM. The Immunomodulatory Functions of Butyrate. J Inflamm Res. 2021;14:6025\u201341. https:\/\/doi.org\/10.2147\/JIR.S300989.","journal-title":"J Inflamm Res"},{"issue":"5","key":"4889_CR75","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.jcmgh.2021.02.007","volume":"11","author":"S Ghosh","year":"2021","unstructured":"Ghosh S, Whitley CS, Haribabu B, Jala VR. Regulation of Intestinal Barrier Function by Microbial Metabolites. Cell Mol Gastroenterol Hepatol. 2021;11(5):1463\u201382. https:\/\/doi.org\/10.1016\/j.jcmgh.2021.02.007.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"1","key":"4889_CR76","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/cei.13397","volume":"199","author":"MN Quraishi","year":"2020","unstructured":"Quraishi MN, Shaheen W, Oo YH, Iqbal TH. Immunological mechanisms underpinning faecal microbiota transplantation for the treatment of inflammatory bowel disease. Clin Exp Immunol. 2020;199(1):24\u201338. https:\/\/doi.org\/10.1111\/cei.13397.","journal-title":"Clin Exp Immunol"},{"key":"4889_CR77","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.3389\/fmicb.2019.02498","volume":"10","author":"Z Wang","year":"2019","unstructured":"Wang Z, Hua W, Li C, Chang H, Liu R, Ni Y, Sun H, Li Y, Wang X, Hou M, Liu Y, Xu Z, Ji M. Protective Role of Fecal Microbiota Transplantation on Colitis and Colitis-Associated Colon Cancer in Mice Is Associated With Treg Cells. Front Microbiol. 2019;10:2498. https:\/\/doi.org\/10.3389\/fmicb.2019.02498.","journal-title":"Front Microbiol"},{"issue":"2","key":"4889_CR78","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3390\/pathogens10020152","volume":"10","author":"P Adamkova","year":"2021","unstructured":"Adamkova P, Hradicka P, Gancarcikova S, Kassayova M, Ambro L, Bertkova I, Maronek M, Farkasova Iannaccone S, Demeckova V. Single Donor FMT Reverses Microbial\/Immune Dysbiosis and Induces Clinical Remission in a Rat Model of Acute Colitis. Pathogens. 2021Feb 2;10(2):152. https:\/\/doi.org\/10.3390\/pathogens10020152.","journal-title":"Pathogens"},{"issue":"1","key":"4889_CR79","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/biomedicines12010043","volume":"12","author":"S Lauko","year":"2023","unstructured":"Lauko S, Gancarcikova S, Hrckova G, Hajduckova V, Andrejcakova Z, Fecskeova LK, Bertkova I, Hijova E, Kamlarova A, Janicko M, Ambro L, Kvakova M, Gulasova Z, Strojny L, Strkolcova G, Mudronova D, Madar M, Demeckova V, Nemetova D, Pacuta I, Sopkova D. Beneficial Effect of Faecal Microbiota Transplantation on Mild, Moderate and Severe Dextran Sodium Sulphate-Induced Ulcerative Colitis in a Pseudo Germ-Free Animal Model. Biomedicines. 2023Dec 22;12(1):43. https:\/\/doi.org\/10.3390\/biomedicines12010043.","journal-title":"Biomedicines"},{"key":"4889_CR80","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3389\/fimmu.2017.00824","volume":"8","author":"M Li","year":"2017","unstructured":"Li M, Wang B, Sun X, Tang Y, Wei X, Ge B, Tang Y, Deng Y, He C, Yuan J, Li X. Upregulation of Intestinal Barrier Function in Mice with DSS-Induced Colitis by a Defined Bacterial Consortium Is Associated with Expansion of IL-17A Producing Gamma Delta T Cells. Front Immunol. 2017;8:824. https:\/\/doi.org\/10.3389\/fimmu.2017.00824.","journal-title":"Front Immunol"},{"key":"4889_CR81","doi-asserted-by":"publisher","unstructured":"Lee JS, Tato CM, Joyce-Shaikh B, Gulen MF, Cayatte C, Chen Y, Blumenschein WM, Judo M, Ayanoglu G, McClanahan TK, Li X, Cua DJ. Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability [Erratum in: Immunity 2015 Nov 17;43(5):1022. Gulan, Fatih [corrected to Gulen, Muhammet F]]. Immunity. 2015;43(4):727\u2013738. https:\/\/doi.org\/10.1016\/j.immuni.2015.09.003.","DOI":"10.1016\/j.immuni.2015.09.003"},{"issue":"11","key":"4889_CR82","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.3390\/cells11111851","volume":"11","author":"C Huang","year":"2022","unstructured":"Huang C, Mei Q, Lou L, Huang Z, Fu Y, Fan J, Wang J, Yin N, Zheng Y, Lu Y, Zeng Y. Ulcerative Colitis in Response to Fecal Microbiota Transplantation via Modulation of Gut Microbiota and Th17\/Treg Cell Balance. Cells. 2022;11(11):1851. https:\/\/doi.org\/10.3390\/cells11111851.","journal-title":"Cells"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-04889-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-025-04889-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-04889-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T15:10:41Z","timestamp":1745248241000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-025-04889-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4889"],"URL":"https:\/\/doi.org\/10.1186\/s12906-025-04889-9","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"8 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All subjects gave their informed consent for inclusion before they participated in the study. The study was conducted in accordance with the Declaration of Helsinki 1964 and its later amendments or comparable ethical standards. The study protocol was approved by the Ethics Committee of Louis Pasteur University Hospital in Ko\u0161ice (2018\/EK\/1001). Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"145"}}